
# AI-Powered Medical Review Report System
**Stage:** Problem Framing & Scoping (Stage 01)

## Problem Statement
Clinical trial and drug regulatory documents are often lengthy, heterogeneous, and time-consuming to review manually. Regulatory reviewers must identify relevant evidence, verify whether submitted materials satisfy compliance requirements, and summarize their findings into structured review reports. This process involves substantial repetitive document search and information-matching work, which can slow down review and increase inconsistency.

This project aims to develop an AI-powered medical review report system that assists reviewers by converting raw documents into standardized text, retrieving relevant evidence, and generating structured review reports. The project will be considered successful if the system improves information-retrieval quality while reducing manual review time, with a target of approximately 30% reduction in review effort compared with a fully manual workflow.

## Stakeholder & User
The primary stakeholders are regulatory review organizations and compliance decision-makers responsible for ensuring the quality, consistency, and efficiency of clinical trial and drug regulatory review.

The primary end users are medical and regulatory reviewers who directly examine large volumes of clinical and regulatory documents, retrieve relevant evidence, and prepare review reports. The system is intended to support, rather than replace, expert judgment by reducing repetitive document-processing and information-retrieval work.

## Useful Answer & Decision
The project primarily provides a **descriptive** answer. It retrieves, organizes, and summarizes information already contained in clinical and regulatory documents rather than predicting future outcomes or estimating causal effects.

The main artifact is an **AI-assisted medical review report system** that retrieves relevant supporting evidence and generates structured review reports. Key evaluation metrics include retrieval accuracy, relevance of retrieved evidence, text-matching quality, and reduction in manual review time.

The output helps reviewers determine whether submitted documents contain sufficient and relevant evidence for further regulatory evaluation.

## Assumptions & Constraints
- Source documents can be converted into machine-readable text or Markdown.
- Human regulatory reviewers remain responsible for final review decisions.
- Generated content must be grounded in the original source documents.
- LLM-generated outputs may contain hallucinations and therefore require human verification.
- Medical and regulatory terminology may vary across documents.
- Access to clinical and regulatory documents may be restricted by privacy and confidentiality requirements.
- Regulatory standards and review requirements may change over time.

## Known Unknowns / Risks
- Retrieval performance may vary across different document types and formats.
- Relevant evidence may be missed when terminology differs substantially across documents.
- Generated reports may omit important evidence or include unsupported statements.
- Automated evaluation metrics may not fully capture regulatory review quality.
- Expert judgment may be required to evaluate the correctness and usefulness of generated reports.

## Lifecycle Mapping
- Improve the efficiency and consistency of clinical and drug regulatory document review → Problem Framing & Scoping (Stage 01) → A clearly defined AI-assisted review system with identified stakeholders, success criteria, constraints, risks, and expected outputs.

## Repo Plan
- `data/raw/` — raw clinical and regulatory documents
- `data/processed/` — cleaned and standardized text chunks
- `src/` — preprocessing, retrieval, ranking, and generation code
- `notebooks/` — exploratory analysis and experiments
- `docs/` — project documentation and stakeholder materials
- `reports/` — generated review reports and evaluation results
- `model/` — model configurations and saved artifacts
